What the Recent White House Announcement Means for Fertility Patients at CRM

On October 16, President Trump announced new initiatives aimed at expanding access to fertility care across the U.S. While the announcement has sparked national interest and optimism, it’s important to understand what these proposals mean for patients currently navigating their fertility journey. 

For the most up-to-date information, we encourage you to visit the Prelude Network website as updates become available. 

Key Takeaways from the Announcement 

• Discounted IVF Medications via TrumpRx. Beginning January 2026, a new government-supported platform—TrumpRx.gov—will offer discounts on three widely used IVF medications from EMD Serono: Gonal-f®, Ovidrel®, and Cetrotide®. 

• Employer Fertility Benefits. New federal guidance encourages employers to offer standalone infertility benefits, similar to dental or vision plans. These benefits are optional and not federally mandated or subsidized. 

• FDA Fast-Tracking Fertility Drug Approval. The FDA will prioritize review of Pergoveris, a fertility medication from EMD Serono, to accelerate its availability in the U.S. 

For more details, see: Reuters — White House set to announce proposal seeking to make IVF more accessible 

What This Means for Patients at Center for Reproductive Medicine 

While these initiatives are promising, they are not yet in effect. Here’s what our patients should know as we look ahead to 2026: 

• If you’re currently undergoing treatment: Your medication plan will remain unchanged. Once discounts become available, our team will help assess eligibility for future cycles. 

• If you’re planning IVF: Medication costs may decrease in 2026. We’ll keep you informed as TrumpRx launches and pricing details are finalized. 

• If your employer offers insurance: You may see expanded fertility benefits in the future. 

• For all patients: Lower medication costs and broader coverage could make IVF more accessible for many families. We’ll continue to monitor these developments and share updates as they unfold. 

Important Considerations 

• TrumpRx is not yet live. It is expected to launch in January 2026, but no official date has been confirmed. 

• Discounts apply only to select EMD Serono medications, which may not be used in every treatment plan. 

• Center for Reproductive Medicine remains committed to providing clear, compassionate guidance as these changes take shape. 

For more details, see: Reuters — White House set to announce proposal seeking to make IVF more accessible